AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials.

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Part of Google Earth Engine, AlphaEarth Foundations is a chip off Google’s DeepMind AI block—and it's here to help save the ...

Google DeepMind says in a new research paper that human-level AI could plausibly arrive by 2030 and "permanently destroy humanity." ...

An artificial intelligence system built by Google DeepMind, the tech giant’s primary artificial intelligence lab, has ...